Publication: Anti-lymphocyte, anti-monocyte, and anti-endothelial cell antibodies in chronic haemodialysis patients
No Thumbnail Available
Date
1992
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Patients receiving chronic haemodialysis treatment are known to have a high prevalence of anti-panel antibodies (anti-lymphocyte, antimonocyte, and anti-endothelial cell) originating from a number of different possible sensitizing events such as blood transfusions, multiparity, or renal transplantation. © 1992 European Dialysis and Transplant Association-European Renal Association.
Description
Keywords
Chronic haemodialysis, Panel-reactive antibodies, Sensitization, Transfusion